EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour

Sebastiaan Bijttebier, Tri-Hung Nguyen, Michelle P McIntosh, Carl Kirkpatrick iD, Bart Remmerie, Lieve Dillen, Pete Lambert

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Sebastiaan Bijttebier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Pharmaceutica, Bioanalytical Discovery & Development Sciences, Beerse, Belgium. Hauptthemen laut MEDLINE: Oxytocin, Tandem Mass Spectrometry, Oxytocics, Postpartum Hemorrhage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Janssen Pharmaceutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide. To prevent PPH, the WHO recommends administration of oxytocin (OT) immediately after birth, i.e. during the third stage of labour (TSL). Previous studies demonstrate that methods to quantify OT in biological matrices, e.g. enzyme‐linked immunosorbent assays (ELISA), radioimmunoassays (RIA) and liquid chromatography–tandem mass spectrometry (LC–MS/MS) lack the specificity and/or sensitivity to accurately quantify OT in plasma from women administered OT during TSL. This is due to increased metabolic clearance of OT in late‐stage pregnancy and at the time of childbirth, resulting in extremely low OT plasma concentrations. This study describes the development of an ultra‐sensitive bioanalytical method that overcomes the issues previously reported and enables accurate pharmacokinetic analyses of exogenously administered OT in TSL.

Methods

A selective and sensitive assay to quantify OT in TSL plasma was developed. Immunoprecipitation (IP) was applied to selectively extract OT from the TSL plasma, thereby generating clean extracts compatible with nanoflow LC (nLC). nLC–MS/MS was chosen for its high sensitivity and ability to differentiate between OT and potentially co‐captured OT‐like immunoreactive products.

Results

The presented methodology is accurate and precise, with a good linear fit between 100–10 000 fg mL −1 OT. TSL plasma samples from a clinical phase 1 study (NCT02999100) were analysed successfully, enabling OT quantification down to 100 fg mL −1 .

Conclusions

The presented IP–nLC–MS/MS method succeeded in overcoming the sensitivity challenge related to the assay of OT in TSL plasma and thereby revealing the PK profiles of OT in TSL plasma clinical study samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxytocinTandem Mass SpectrometryOxytocicsPostpartum HemorrhageHumansFemalePregnancyChromatography, LiquidAdultSensitivity and SpecificityLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

immunoprecipitationliquid chromatography–tandem mass spectrometryoxytocinpharmacokinetic profilesthird stage of labour

Substanzen

OxytocinOxytocics

Autor:innen und Institutionen

  • Janssen Pharmaceutica, Bioanalytical Discovery & Development Sciences, Beerse, Belgium.
  • Drug Delivery Disposition and Dynamics, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.
  • Janssen Pharmaceutica, Clinical Pharmacology, Beerse, Belgium.

ORCID-Profile: Carl Kirkpatrick

Förderung

  • Janssen Pharmaceutica

Zitieren

APA

Bijttebier, S., Nguyen, T. H., McIntosh, M. P., Kirkpatrick, C., Remmerie, B., Dillen, L., & Lambert, P. (2024). Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16135

Vancouver

Bijttebier S, Nguyen TH, McIntosh MP, Kirkpatrick C, Remmerie B, Dillen L, et al. Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16135

BibTeX
@article{Bijttebier2024,
  author = {Bijttebier, Sebastiaan and Nguyen, Tri-Hung and McIntosh, Michelle P and Kirkpatrick, Carl and Remmerie, Bart and Dillen, Lieve and Lambert, Pete},
  title = {Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16135}
}
Kostenlos starten →